Link to this page
PMO Precision Medicine Ontology
Last uploaded:
December 16, 2020
Jump to:
| Preferred Name | Linagliptin | |
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00017784 |
|
| Database_Cross_Reference |
NDDF:013732 NDFRT:N0000191976 VANDF:4030725 NCI:C83887 RXNORM:1100699 DRUGBANK:DB08882 SNOMEDCT_US:703667006 MMSL:d07767 MSH:D000069476 ATC:A10BH05 NDFRT:N0000182735 MEDCIN:308147 SNOMEDCT_US:702798009 USPMG:MTHU002754 MMSL:27861 MTHSPL:3X29ZEJ4R2 NCI_FDA:3X29ZEJ4R2
|
|
| label |
Linagliptin
|
|
| MCID |
MC00759096
|
|
| PMOID |
PMO:00017784
|
|
| prefixIRI |
pmo:PMO_00017784
|
|
| prefLabel |
Linagliptin
|
|
| Synonym |
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (R)-8-(3-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione 1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- Linagliptin (substance) linagliptin (medication) 8-((3R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-3,7-Dihydro-1H-Purine-2,6-Dione Linagliptin [Chemical/Ingredient] oral hypoglycemics linagliptin linagliptin (R)-8-(3-Amino-Piperidin-1-yl)-7-but-2-ynyl-3-Methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione LINAGLIPTIN 1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- Linagliptin (product)
|
|
| Tree Number |
T6.16.1.1.3.1 T6.16.1.1.1.3
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping